我国生物医药企业发展建议

近年来,国外生物医药产业发展迅速,在发达国家,生物医药产品在药品市场中已占有了重要地位,哺乳动物细胞表达的产品已经占据生物医药的主流地位。相比之下,我国生物医药品种主要采用简单的大肠杆菌、酵母表达技术,技术难度较高的哺乳动物细胞药品与国外差距显著,因此,哺乳动物表达的生物药品将成为国内生物医药企业的重要发展机会。多年来,鉴于我国从发达国家获得生物技术转让少,国内生物医药发展需立足于自主研发,建立高效的研发技术平台,选择合适的开发项目,促进企业的发展。

Development proposal for Biopharmaceutical Industry

Biotech is currently the fastest growing sector in the drug industry. Globally biotech products generated revenues of $55bn in 2004, in a total drug market worth $550bn. The USA is the primary market for biotech products, being the source of approximately half of sales in 2004. 54.5% of biopharmaceuticals' sales in 2004 came from the leading 5 products. Great progress has been made in the Chinese biotech market over the last few years. About 60%-70% of recombinant protein biopharmaceuticals are expressed by mammalian cell in USA and EU, while most recombinant protein biopharmaceuticals are expressed by E.coli in China. Most biopharmaceuticals expressed by mammalian cell can't be manufactured in China. The biotech industry comprise numerous, mostly small organization. Each one typically employs fewer than 100 people. Most biotech companies have never brought a product to market before they come to die. Making a appropriate development strategy for biotech company is very necessary.